/LCDX

LCDX Stock - Caliber Imaging & Diagnostics, Inc.

Q: What is the analyst price target for LCDX?

Analyst price target information is not currently available for LCDX.

Q: What is LCDX's market cap?

Market capitalization information is not currently available for LCDX.

Healthcare|Medical - Devices|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

High Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

100

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for LCDX

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2009

FY2010

FY2011

FY2012

FY2013

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.09

52W High$0.02

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2013	FY2012	FY2011	FY2010	FY2009
Revenue	$3.34M	$2.43M	$3.58M	$2.63M	$2.30M
Gross Profit	$653,856	$32,856	$1.69M	$1.48M	$1.24M
Gross Margin	19.6%	1.3%	47.2%	56.5%	53.8%
Operating Income	$-4,852,694	$-8,347,638	$-6,568,404	$-3,555,667	$-3,544,748
Net Income	$-5,479,251	$-9,820,625	$-9,053,764	$-4,302,917	$-4,051,351
Net Margin	-164.0%	-403.4%	-253.1%	-163.8%	-176.0%
EPS	$-0.65	$-1.23	$-7.37	$-1.99	$-1.87

Company Overview

Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.

Visit Website

Frequently Asked Questions about LCDX

What is LCDX's current stock price?

Caliber Imaging & Diagnostics, Inc. (LCDX) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for LCDX?

No analyst price targets are currently available for this stock.

What sector is Caliber Imaging & Diagnostics, Inc. in?

Caliber Imaging & Diagnostics, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.

What is LCDX's market cap?

Caliber Imaging & Diagnostics, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does LCDX pay dividends?

No, Caliber Imaging & Diagnostics, Inc. does not currently pay a dividend to shareholders.